How to Read a Peptide Certificate of Analysis (COA): A Researcher's 2026 Guide

A complete researcher's guide to the analytical evidence behind every peptide vial — identity, purity, sterility, endotoxin, stability — and how to spot a weak COA in seconds.

June 06, 2026 12 MIN READ By American Peptides Research Team

How to Read a Peptide Certificate of Analysis (COA)

What is a peptide Certificate of Analysis? A peptide Certificate of Analysis (COA) is a document issued by an analytical laboratory that reports the measured identity, purity, and quality attributes of a specific synthesized batch. A complete COA confirms the peptide's molecular structure via mass spectrometry, reports purity via high-performance liquid chromatography (HPLC), documents residual solvents and counterions, and ties every measurement to a traceable batch number. Researchers read COAs to verify that the compound they receive matches what was ordered.

What is a Certificate of Analysis (COA)?

A Certificate of Analysis is the document that translates raw analytical data into a structured report. Every batch of a synthesized peptide that leaves a credible manufacturer is paired with a COA that captures, at minimum, four categories of measurement: identity (is this molecule what we claim it is?), purity (what fraction of the batch is the target compound vs. impurities?), content (how much actual peptide is in the vial vs. counterions and water?), and safety attributes (endotoxin levels, sterility, residual solvents).

The COA is not marketing material. It is a primary scientific document — the analytical evidence behind a vial. Reading one properly is the single most important skill a research buyer can develop, because every other claim a vendor makes downstream (purity guarantees, batch consistency, lab-verified status) ultimately points back to the data on this page.

The history is worth knowing. The modern COA evolved from the ICH Q6A specification framework — an international guideline for setting specifications for new chemical entities — and from pharmacopeial standards like USP <71> (sterility) and USP <85> (bacterial endotoxins). Research-grade peptide manufacturers don't operate under ICH compliance, but the format of a credible peptide COA still mirrors that lineage. Vendors who skip the format altogether are usually skipping the underlying testing too.

The 5 Layers of Peptide Quality

Most COA explainers treat the document as a flat checklist. That misses the structure of why each test exists. We organize peptide quality into five sequential layers, each of which a COA documents through a specific analytical method:

``┌─────────────────────┐ │ 5. STABILITY │ ← shelf-life integrity ├─────────────────────┤ │ 4. ENDOTOXIN │ ← microbial contamination floor ├─────────────────────┤ │ 3. STERILITY │ ← microbial presence ├─────────────────────┤ │ 2. PURITY │ ← target vs. impurities ├─────────────────────┤ │ 1. IDENTITY │ ← is it the right molecule? └─────────────────────┘`

A COA that documents only purity has confirmed only the second layer. A COA that documents identity, purity, sterility, endotoxin, and stability is a complete record. The rest of this article walks through each layer in the order the testing actually happens in a lab.

Identity — How analytical chemistry confirms what's in the vial

Identity testing answers a single question: is the molecule in this vial the one we synthesized for? For a peptide, identity is established by three orthogonal methods, in increasing rigor:

Mass spectrometry (MS). A mass spectrometer ionizes the peptide and measures its mass-to-charge ratio. Every peptide has a theoretical monoisotopic mass that can be calculated from its amino acid sequence; a credible COA reports both the theoretical mass and the observed mass, which should agree within a fraction of a Dalton. When you see a line like "Observed: 1620.78, Theoretical: 1620.79" on a COA, you are looking at identity confirmation.

High-performance liquid chromatography (HPLC) retention time. When the peptide is run through an HPLC column, it elutes at a characteristic retention time. A second sample of the same peptide should elute at the same retention time. Identity COAs cite retention time as a corroborating signal.

Sequence verification (where applicable). Some labs perform tandem mass spectrometry (MS/MS) to fragment the peptide and verify the amino acid sequence directly. This is the gold standard and is more common in pharmaceutical settings than in research-grade COAs.

A COA that lists only "identity confirmed" without underlying data has not confirmed identity to a reader — it has merely asserted it.

Purity — Reading the HPLC chromatogram

Purity is the most cited number on a peptide COA and the most misunderstood. Purity is not "how strong the peptide is." Purity is the percentage of the analyzed sample that is the target peptide rather than impurities — truncated sequences from incomplete coupling, oxidized variants, deletion sequences, deprotection byproducts, or trace solvent.

The standard analytical method is reversed-phase HPLC with UV detection at 220 nm (or 214 nm, sometimes 280 nm — wavelength choice matters and a credible COA states it). The output is a chromatogram: a baseline with peaks, where each peak represents a compound eluting from the column at a specific time. The target peptide is usually the dominant peak. Purity is calculated as:

> Purity (%) = (Area of target peak / Total area of all peaks) × 100

A few things to look for when reading the chromatogram on a COA:

The baseline should be flat and stable before and after the major peak. A drifting or noisy baseline can mask small impurities.
The target peak should be sharp and symmetric. A peak with significant shoulders or tailing suggests co-eluting impurities the integration may not have separated.
The integration should account for all peaks, not just the major one. Some COAs report only the target peak area; a credible report shows the full chromatogram trace with all integrated peaks.
Detector wavelength matters. A peptide measured at 220 nm picks up the peptide bond. A peptide measured only at 280 nm captures aromatic side chains and may underreport non-aromatic impurities.

What does 99% mean? It means that, under the specific HPLC conditions reported, 99% of the integrated UV-absorbing material was the target peak. A 99% peptide can still contain ~1% impurities by mass. For research applications where downstream assays are sensitive to those impurities, the chromatogram is more informative than the headline number.

Mass — Confirming molecular weight with LC-MS

LC-MS (liquid chromatography coupled to mass spectrometry) does two jobs in one run: it separates the sample by HPLC, then measures the mass of each peak as it elutes. For peptide identity, a credible COA reports:

Theoretical monoisotopic mass (calculated from sequence)
Observed monoisotopic mass (measured)
Charge state(s) observed (typically M+H⁺, M+2H²⁺, M+3H³⁺ for peptides under electrospray ionization)
Mass accuracy (in parts per million or Daltons)

Modern high-resolution mass spectrometers achieve sub-ppm mass accuracy, meaning a peptide of mass 1620.79 Da can be measured to within ~0.002 Da. A COA that reports masses to two decimal places, with stated charge states, is documenting a high-resolution analysis. A COA that simply reports "MS confirmed" without numbers is documenting nothing reproducible.

Residual content — Solvents, counterions, and water

This is the layer that drops off many vendor COAs entirely, and where the gap between research-grade and pharmaceutical-grade analysis becomes most visible. A lyophilized peptide vial does not contain pure peptide. It contains:

The target peptide
Counterions from the trifluoroacetic acid (TFA) or acetate buffer used in purification — typically 5–30% of total vial mass
Residual water even after lyophilization — typically 1–10%
Residual organic solvents from synthesis and purification (acetonitrile, DMF, methanol, TFA)

A complete COA reports:

Water content by Karl Fischer titration
Counterion content by ion chromatography or NMR
Residual solvents by gas chromatography (GC), per ICH Q3C limits

The practical implication for researchers: a vial labeled "10 mg peptide" measured at 99% HPLC purity but with 20% TFA counterion and 5% water actually contains roughly 7.5 mg of net peptide. This is why the "net peptide content" line on a high-quality COA — when present — is more informative than the label weight.

Sterility and endotoxin — The microbiological pillars

For research peptides reconstituted in solution, microbial contamination matters. Two tests anchor this layer:

Sterility testing (USP <71>): Confirms the absence of viable microorganisms. The compendial method is a 14-day incubation in two growth media (fluid thioglycollate medium and soybean-casein digest broth), evaluating for visible growth.

Bacterial endotoxin testing (USP <85>): Quantifies endotoxins (lipopolysaccharides from gram-negative bacterial cell walls). Even a sterile sample can contain endotoxins from upstream contamination. The classic method is the LAL (Limulus amebocyte lysate) test; modern alternatives include recombinant Factor C (rFC). Results are typically reported in EU/mg (endotoxin units per milligram).

A COA that reports sterility and endotoxin testing has documented two additional layers most research vendors skip. Their presence is a meaningful trust signal.

Stability and storage data

Stability is the layer most COAs treat as a footnote and many skip entirely. A complete batch record should include:

Recommended storage conditions (typically -20°C lyophilized, 4°C reconstituted short-term)
Stability period at recommended conditions
Stress-test data (heat, light, freeze-thaw cycles) where available

The underlying chemistry matters: peptides degrade through oxidation (especially methionine, tryptophan, cysteine residues), deamidation (asparagine, glutamine), hydrolysis (aspartate-proline bonds are particularly labile), and aggregation. A COA tied to a documented stability study is communicating that the manufacturer has actually measured how long the molecule holds up — not just guessed.

Batch information and traceability

This is the boring section that quietly separates a real COA from a fabricated one. Every credible COA includes:

Manufacturer name and lot number
Synthesis date
Test date(s) — distinct from synthesis date
Analyst initials or signature
Method references (e.g., "HPLC method MN-001, rev 3")
Expiration or re-test date

If you reorder the same compound and receive a new vial, the new lot's COA should be a different document with a new lot number and new test dates — not a copy of the previous one. A vendor sending the same COA across multiple lots is either not testing each batch or is willing to mislead about which batch was tested. Both are disqualifying.

The Research Validation Pyramid

Reading a single COA confirms a single batch. Confirming the integrity of an entire vendor's supply chain is a higher-order task. We organize that evaluation as a five-layer pyramid:

`/\ / \ ← 5. Lot retention /────\ (vendor archives samples for retest) / \ ← 4. Cold-chain documentation /────────\ (storage, packaging, transit) / \ ← 3. Batch traceability /────────────\ (every PO ties to a unique lot) / \ ← 2. Independent verification /────────────────\ (third-party lab confirms identity) / \ ← 1. Internal COA /────────────────────\ (the document itself)``

A vendor sitting at layer 1 has provided a document. A vendor at layer 5 has built an auditable quality system. The further up the pyramid you can verify, the lower your project risk for sensitive research.

Red flags — How to spot a weak or fabricated COA

After enough COA review, patterns emerge. The most common red flags:

Stock template language with batch-specific fields left as placeholders ("Lot: XXXXX")
HPLC purity claimed without a chromatogram image attached
MS confirmed without theoretical/observed masses or a spectrum
No analyst signature or lab name — only a logo
Identical COAs across multiple ordered lots (different lot numbers should mean different test dates)
Purity stated to inappropriate precision ("99.997%" is not a meaningful HPLC integration)
No detector wavelength stated on HPLC purity reports
No counterion or residual water data despite the peptide being lyophilized
Stability claims without an underlying study reference
*A COA dated before* the lot synthesis date (yes, this happens)

None of these in isolation is conclusive — small labs sometimes use templates and small batches sometimes share methods. But three or more together is a strong signal that the COA may be reporting less than it appears.

Why third-party verification matters

The most rigorous trust signal a COA can carry is third-party verification: an independent analytical lab, unaffiliated with the manufacturer, that has tested the same lot and reports concordant results. Third-party verification doesn't replace internal QC — it cross-validates it. When two independent measurements agree, the probability that both are mistaken in the same direction drops sharply.

For research applications where the cost of a contaminated or misidentified compound is wasted experiments, lost time, and unreproducible results, third-party verification is the highest-leverage trust signal available. It is also the one most absent from the broader research-peptide market.

Frequently asked questions

What does 99% peptide purity actually mean?**
It means that, under the HPLC conditions reported on the COA, 99% of the integrated UV-absorbing material in the analyzed sample was the target peak. Peptide purity does not describe peptide content — that requires separate water, counterion, and net-peptide measurements.

Is HPLC the only way to measure peptide purity?
HPLC is the standard analytical method for purity in peptide chemistry, but it is most informative when paired with mass spectrometry for identity confirmation. A purity number without an identity confirmation does not establish that the major peak is actually the target peptide.

What is a counterion on a peptide COA?
A counterion is an ion paired with the peptide during synthesis or purification — most commonly trifluoroacetate (TFA) from reversed-phase HPLC purification, sometimes acetate. The counterion contributes mass to the lyophilized vial but is not part of the peptide molecule itself.

How can a researcher verify that a COA is authentic?
Look for batch-specific data (lot number, synthesis date, test dates, analyst signature), attached analytical traces (chromatograms, mass spectra), and independent verification from a third-party lab. Cross-reference the lot number with any prior orders to confirm the document is not being recycled across batches.

Why do some COAs list residual TFA and others don't?
TFA is a strong-acid counterion commonly introduced during reversed-phase HPLC purification. Measuring it requires a separate analytical method (typically NMR or ion chromatography). COAs that omit residual TFA either have not measured it or have used a synthesis route that avoided it.

What is the difference between USP <71> and USP <85>?
USP <71> is the United States Pharmacopeia chapter on sterility testing — the detection of viable microorganisms. USP <85> is the chapter on bacterial endotoxin testing — the quantification of pyrogenic lipopolysaccharide. A sample can pass USP <71> and still fail USP <85>, because endotoxins persist after the bacteria that produced them are killed.

What does ICH Q3C have to do with peptide COAs?
ICH Q3C is the International Council for Harmonisation guideline on residual solvents. It defines acceptable limits for organic solvents (acetonitrile, DMF, methanol, etc.) in a final product. Credible COAs reference Q3C class limits when reporting residual solvent measurements.

How often should a manufacturer re-test a peptide for stability?
Standard practice is to perform stability studies at multiple time points (e.g., 0, 3, 6, 12, 24 months) under defined storage conditions, and to set a re-test date on the COA accordingly. Without an underlying study, a stated shelf life is a guess.

Key takeaways

A peptide COA is the analytical evidence behind a vial — not marketing material.
Five layers of peptide quality, in order: identity, purity, sterility, endotoxin, stability.
Purity (HPLC) is the most-cited and most-misunderstood number — read the chromatogram, not just the percentage.
Identity requires mass spectrometry with theoretical and observed masses reported.
Residual water, counterions, and solvents change the net peptide content in the vial.
Sterility (USP <71>) and endotoxin (USP <85>) are the microbiological pillars — most research vendors skip them.
Batch traceability and independent verification are the high-trust signals.
The same COA across multiple lots is a disqualifying red flag.